Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Signal Transduction Society

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. STKE, 15 February 2005
Vol. 2005, Issue 271, p. cm1
[DOI: 10.1126/stke.2712005cm1]

CONNECTIONS MAP OVERVIEWS

Wnt/beta-Catenin Pathway

Randall T. Moon*

HHMI, Department of Pharmacology, Center for Developmental Biology, University of Washington School of Medicine, Seattle, WA 98195,USA.

Abstract: Wnts are secreted glycoproteins that act as ligands to stimulate receptor-mediated signal transduction pathways in both vertebrates and invertebrates. Activation of Wnt pathways can modulate cell proliferation, survival, cell behavior, and cell fate in both embryos and adults. The Wnt/beta-catenin pathway is the best understood Wnt signaling pathway, and its core components are highly conserved during evolution, although tissue-specific or species-specific modifiers of the pathway are likely. In the absence of a Wnt signal, cytoplasmic beta-catenin is phosphorylated and degraded in a complex of proteins. Wnt signaling through the Frizzled serpentine receptor and low-density lipoprotein receptor-related protein-5 or -6 (LRP5 or 6) coreceptors activates the cytoplasmic phosphoprotein Dishevelled, which blocks the degradation of beta-catenin. As the amount of beta-catenin rises, it accumulates in the nucleus, where it interacts with specific transcription factors, leading to regulation of target genes. Inappropriate activation of the pathway in response to mutations is linked to a wide range of cancers, including colorectal cancer and melanoma. The pathway is linked to bone density syndromes and to neurodegenerative diseases, and the pathway may also be involved in the retinal disease familial exudative vitreoretinopathy.

*Contact information. Telephone, 206-543-1722; fax, 206-543-0858; e-mail, rtmoon{at}u.washington.edu

Citation: R. T. Moon, Wnt/ß-Catenin Pathway. Sci. STKE 2005, cm1 (2005).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Suppressing Wnt Signaling by the Hedgehog Pathway through sFRP-1.
J. He, T. Sheng, A. A. Stelter, C. Li, X. Zhang, M. Sinha, B. A. Luxon, and J. Xie (2006)
J. Biol. Chem. 281, 35598-35602
   Abstract »    Full Text »    PDF »
Wnt/{beta}-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation.
K. K. Mak, M.-H. Chen, T. F. Day, P.-T. Chuang, and Y. Yang (2006)
Development 133, 3695-3707
   Abstract »    Full Text »    PDF »
The Multiple Languages of Endothelial Cell-to-Cell Communication.
S. Liebner, U. Cavallaro, and E. Dejana (2006)
Arterioscler. Thromb. Vasc. Biol. 26, 1431-1438
   Abstract »    Full Text »    PDF »
Dishevelled (Dvl-2) activates canonical Wnt signalling in the absence of cytoplasmic puncta.
M. J. Smalley, N. Signoret, D. Robertson, A. Tilley, A. Hann, K. Ewan, Y. Ding, H. Paterson, and T. C. Dale (2005)
J. Cell Sci. 118, 5279-5289
   Abstract »    Full Text »    PDF »
{beta}-Catenin, Cancer, and G Proteins: Not Just for Frizzleds Anymore.
C. C. Malbon (2005)
Sci. STKE 2005, pe35
   Abstract »    Full Text »    PDF »

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)